Zevra Therapeutics, Inc. (ZVRA) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Cash from Operations | 6.14M | 5.52M | 4.71M | -3.6M | -8.22M | -16.25M | -18.14M | -19.11M | -16.16M | -16.16M | -4.63M | -8.7M | -4.04M | -4.46M | -6.6M | -4.17M | -3.48M | -848K | -2.73M | 16.6M |
| Operating CF Margin % | 16.96% | 16.16% | 18.07% | -13.91% | -40.3% | -134.93% | -490.96% | -429.51% | -471.97% | -122.25% | -159.86% | -102.76% | -127.36% | -192.41% | -229.58% | -320.92% | -87.89% | -32.84% | -138.93% | 138.52% |
| Operating CF Growth % | 174.7% | 133.94% | 125.96% | 81.16% | 49.14% | -0.57% | -291.98% | -119.54% | -299.63% | -262.12% | 29.86% | -108.63% | -16.07% | -426.18% | -141.69% | -125.13% | -34.76% | 19.92% | -159.75% | 657.09% |
| Net Income | 36.32M | 12.16M | -544K | 74.71M | -3.1M | -35.74M | -33.23M | -19.93M | -16.62M | -15.15M | -14.04M | -2.57M | -13.22M | 5.75M | -6.62M | -24.04M | -1.86M | -2.7M | -1.76M | 6.2M |
| Depreciation & Amortization | 368K | 362K | 392K | 1.65M | 1.65M | 1.65M | 1.62M | 1.56M | 1.56M | 787K | 62K | 78K | 79K | 300K | 398K | 181K | 65K | 64K | 65K | 64K |
| Stock-Based Compensation | 0 | 4.28M | 2.77M | 2.46M | 3.12M | 4.02M | 6.14M | 2.63M | 2.12M | 2.96M | 1.39M | 2.15M | 945K | 0 | 911K | 1.51M | 918K | 823K | 620K | 318K |
| Deferred Taxes | 0 | 501K | -433K | 2.2M | 1.18M | 0 | 0 | 0 | 0 | -6.63M | -5.56M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -40.13M | -1.75M | 4.85M | -77.33M | -4.22M | 12M | 7.57M | -1.94M | -3.08M | 5M | 5.77M | -2.03M | 1.15M | -14M | 182K | 17.83M | 161K | 9K | -259K | -239K |
| Working Capital Changes | 9.59M | -10.05M | -2.33M | -7.29M | -6.84M | 1.83M | -239K | -1.44M | -148K | -3.12M | 7.76M | -6.33M | 7M | 3.49M | -1.47M | 346K | -2.77M | 959K | -1.4M | 10.26M |
| Change in Receivables | 6.89M | -6.37M | 1.36M | -4.86M | -2.11M | -3.36M | 1.16M | -642K | 9.07M | -7.45M | 4.11M | -6.21M | 477K | -2.13M | -3.35M | 500K | -1.79M | 91K | 269K | 9.42M |
| Change in Inventory | -185K | -525K | -194K | -381K | -205K | 502K | -583K | -991K | -2.58M | 16K | 65K | 74K | 51K | -133K | 241K | 39K | 0 | 0 | 0 | 0 |
| Change in Payables | -529K | 412K | -4.73M | -4M | -7.26M | 6.99M | -1.99M | -1.3M | -7.31M | 5.34M | 2.45M | -889K | 0 | 1.87M | 0 | 1.05M | -418K | 778K | -189K | 118K |
| Cash from Investing | 79.62M | 227K | -4.58M | 11.93M | 10.54M | -5.47M | -31.35M | -129K | 14.79M | 10.59M | -44.46M | 34.04M | -17.55M | -63K | 272K | -33.08M | -3.85M | -15.44M | -4K | -81K |
| Capital Expenditures | -35K | 31K | -554K | -213K | -99K | 0 | 0 | 0 | 0 | -72K | -172K | -23K | -29K | -34K | -28K | -15K | -16K | -17K | -4K | -81K |
| CapEx % of Revenue | 0.1% | 0.09% | 2.13% | 0.82% | 0.49% | - | - | - | - | 0.54% | 5.94% | 0.27% | 0.91% | 1.47% | 0.97% | 1.15% | 0.4% | 0.66% | 0.2% | 0.68% |
| Acquisitions | 42K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -30.4M | 44.28M | 0 | 0 | 0 | 0 | -14.09M | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 43.94M | -141K | -149.41M | 150M | 0 | 8.92M | 0 | 0 | -14.79M | 0 | -44.28M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | -52.8M | 2.55M | 6.53M | 1.38M | 1.61M | 796K | 64.77M | 15.33M | 1.22M | 5M | 26.26M | 951K | -3.75M | -257K | -409K | 13.82M | -4.8M | -2.87M | 1.94M | 39.75M |
| Debt Issued (Net) | -60.09M | 0 | 0 | 0 | -372K | -16.29M | 0 | 16.29M | 0 | -1.1M | 26.21M | -322K | 112K | -3K | -2K | 12.8M | -10K | -17K | -23K | -72K |
| Equity Issued (Net) | 9.92M | 2.55M | 6.53M | 1.38M | 1.98M | -65.89M | 64.67M | -71K | 1.22M | 6.11M | 53K | 166K | -3.45M | 176K | 0 | 216K | -4.79M | -2.85M | 860K | 4.17M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -3.45M | 0 | 0 | 0 | -4.72M | -2.81M | 0 | 0 |
| Other Financing | -2.63M | 0 | 0 | 0 | 0 | 82.98M | 92K | -889K | 0 | 0 | 0 | 1.11M | -415K | -430K | -407K | 736K | 0 | 0 | 1.1M | 35.65M |
| Net Change in Cash | 33.19M | 7.97M | 6.73M | 10.37M | 3.56M | -20.25M | 14.78M | -3.59M | -200K | -220K | -22.93M | 26.02M | -25.29M | -4.59M | -6.72M | -23.43M | -12.1M | -19.16M | -792K | 56.27M |
| Free Cash Flow | 6.11M | 5.55M | 4.16M | -3.81M | -8.32M | -16.25M | -18.14M | -19.11M | -16.16M | -16.23M | -4.8M | -8.73M | -4.07M | -4.5M | -6.63M | -4.19M | -3.5M | -865K | -2.73M | 16.52M |
| FCF Margin % | 16.86% | 16.25% | 15.94% | -14.74% | -40.79% | -134.93% | -490.96% | -429.51% | -471.97% | -122.8% | -165.8% | -103.03% | -128.27% | -193.88% | -230.55% | -322.08% | -88.3% | -33.5% | -139.13% | 137.84% |
| FCF Growth % | 173.39% | 134.14% | 122.9% | 80.04% | 48.52% | -0.12% | -277.94% | -118.96% | -296.78% | -260.99% | 27.56% | -108.43% | -16.37% | -419.77% | -142.36% | -125.34% | -35.38% | 20.28% | -160.13% | 652.03% |
| FCF per Share | 0.10 | 0.10 | 0.07 | -0.07 | -0.15 | -0.30 | -0.38 | -0.46 | -0.39 | -0.43 | -0.14 | -0.26 | -0.12 | -0.13 | -0.19 | -0.12 | -0.10 | -0.02 | -0.08 | 0.57 |
| FCF Conversion (FCF/Net Income) | 0.16x | 0.45x | -8.66x | -0.05x | 2.65x | 0.45x | 0.55x | 0.96x | 0.97x | 1.07x | 0.45x | 3.38x | 0.31x | 0.49x | 1.00x | 0.17x | 1.87x | 0.31x | 1.55x | 2.68x |
| Interest Paid | 0 | 0 | 1.37M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 68K | 0 | 124K | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |